Nature Communications (Mar 2023)
Structural basis of HIV-1 maturation inhibitor binding and activity
Abstract
HIV maturation inhibitors such as bevirimat (BVM) interfering with Gag processing are emerging as alternative anti-retroviral drug candidates. Here, the authors report structures of assemblies of HIV-1 Gag fragments spanning the CA C-terminal domain and SP1 region bound to BVM.